Mosaic ImmunoEngineering Inc (CPMV)

[Prudent Capitalist]

i think what is hurting the stock more than the restructuring and departures is the strange quarterly report and numbers. Revenue plummeted to hardly anything ($100,000), and there was a loss versus a prior year gain. And, then how do you explain the reported fact that cash and marketable securities increased by $1.4 Million? Where did this come from? Something doesn't seem right about the quarterly report and numbers, and if those of us who have followed the company closely can't figure it out, imagine how it looks to the rest of the investment community. Can anyone shed light on these issues or help me to better understand this?